PhoenixBio Co., Ltd. (6190.T)

JPY 335.0

(-1.76%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 1.71 Billion 2.12 Billion 1.32 Billion 1.01 Billion 1.31 Billion
Cost of Revenue 520.26 Million 567.6 Million 597.02 Million 425.4 Million 445 Million
Gross Profit 1.19 Billion 1.55 Billion 727.79 Million 588.14 Million 865 Million
Operating Expenses 1.18 Billion 1.04 Billion 895.4 Million 865.02 Million 1.28 Billion
Selling, General and Administrative Expenses 132.92 Million 103.59 Million 80.34 Million 79.1 Million 765 Million
Research and Development Expenses 206.86 Million 205.47 Million 219.77 Million 221.11 Million 238 Million
Other Expenses 844.2 Million 12.94 Million 15.18 Million 18.07 Million -
Cost and Expenses 1.7 Billion 1.61 Billion 1.49 Billion 1.29 Billion 1.72 Billion
Operating Income 11.06 Million 508.44 Million -167.61 Million -276.88 Million -147 Million
Interest Expense 2.92 Million 3.07 Million 952 Thousand 1.16 Million 1.54 Million
Income Tax Expense 33.4 Million 17.31 Million -5.03 Million 14.12 Million 1 Million
Earnings before Tax 59.78 Million 510.64 Million -393 Million -223.87 Million -416 Million
Net Income 26.37 Million 493.32 Million -387.97 Million -238 Million -415 Million
Earnings Per Share Basic 6.88 145.23 -117.50 -73.60 -141.60
Earnings Per Share Diluted 6.88 97.29 -117.50 -73.60 -141.60
Weighted Average Shares Outstanding 3.78 Million 3.39 Million 3.3 Million 3.23 Million 2.93 Million
Weighted Average Shares Outstanding (Diluted) 3.78 Million 3.39 Million 3.3 Million 3.23 Million 2.93 Million
Gross Margin 0.70 0.73 0.55 0.58 0.66
EBIT Margin 0.05 0.25 -0.03 -0.18 -0.05
Profit Margin 0.02 0.23 -0.29 -0.23 -0.32
EBITDA 87.93 Million 537.41 Million -305.81 Million -167.26 Million -330.96 Million
Earnings Before Tax Margin 0.01 0.24 -0.13 -0.27 -0.11

Income Statement Charts